Isotechnika appoints new board member
This article was originally published in Scrip
Isotechnika Pharma, a biopharmaceutical company discovering and developing immunosuppressive therapeutics, has appointed Dr Jurgen Engel to its board of directors. Dr Engel is president and CEO of AEterna Zentaris. Prior to this, he served as CEO of ASTA Medica spin-off, Zentaris.